Please login to the form below

Not currently logged in
Email:
Password:

Ron Tilles

This page shows the latest Ron Tilles news and features for those working in and with pharma, biotech and healthcare.

Shkreli fallout claims Turing jobs and KaloBios' listing

Shkreli fallout claims Turing jobs and KaloBios' listing

It will also expand its board. Chairman and interim CEO Ron Tilles said reducing the headcount would "put us in the best position to continue executing on our long-term plan".

Latest news

  • Update: Shkreli resigns as Turing CEO, ousted from KaloBios Update: Shkreli resigns as Turing CEO, ousted from KaloBios

    Shkreli will be replaced on an interim basis by Ron Tilles, Turing Pharma's chairman, at the privately held company, which has offices in New York and Zug in Switzerland. ... In a statement, Tilles thanked Shkreli for his time at Turing and wished him

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics